Symani Restore surgery for Moyamoya disease
Official title: An Early Feasibility Study for the Symani Surgical System
Run by Jacobs institute · NCT07140731 · Data updated 2026-11-12
This study tests using the Symani Surgical System to assist surgeons performing neurosurgery in adults with moyamoya disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 15 (estimated) |
| Sponsor | Jacobs institute Academic / other |
| Locations | 1 site (Buffalo, New York) |
| Status | Recruiting |
| Started | September 20, 2025 |
| Main results expected | September 1, 2027 |
| Study ends | September 1, 2027 |
| Registry record updated | October 16, 2025 |
| Trial ID | NCT07140731 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 with moyamoya disease who have minor to moderate symptoms and are candidates for neurosurgical treatment and general anesthesia are ideal candidates.
✕Probably not a fit
Patients with current or past bleeding/coagulation disorders, those who cannot tolerate prolonged anesthesia, hemodynamically unstable neurological exams, or pressure-dependent neurologic status are unlikely to benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, interventional study of the Symani Surgical System in adults with moyamoya disease who require neurosurgical treatment. Eligible patients (>18 years) will undergo the planned surgical procedure with the aid of the Symani device and will be followed for safety and device-related outcomes. The trial enrolls patients at the Jacobs Institute in Buffalo, New York, and applies standard inclusion and exclusion criteria for operative candidates. Investigators will record perioperative safety, technical performance, and clinical recovery measures to determine device effectiveness in this population.
Why it matters
Potential benefit: If successful, using the Symani system could improve the precision of delicate cerebrovascular procedures and potentially reduce surgical complications.
How similar studies have gone: Robotic-assisted microsurgery has shown promise in other microvascular procedures, but application specifically for moyamoya disease is limited and this study is among the early tests of Symani in this setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients aged \>18. 2. Moyamoya disease with minor to moderate symptoms requiring neurosurgical treatment. 3. Patients agree to have the surgery and the anesthesia. 4. Patients who voluntarily decide to participate in this study with the surgery performed with the aid of Symani and agree to sign the Informed Consent Form. \- Exclusion Criteria: 1. Patients who have bleeding or coagulation disorders in the past or present. 2. Any criteria that preclude prolonged anesthesia. 3. Hemodynamically unstable neurological exam. 4. Pressure dependent neurologic status.
Where it's running
-
Jacobs Institute
Buffalo, New York, United States Recruiting
Study contacts
- Study coordinator: CARLOS PENA, PhD, MS
- Email: cpena@jacobsinstitute.org
- Phone: 17168884814
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Risk prediction for stroke and cognitive decline in Moyamoya disease and Moyamoya syndrome
A large multicenter study tests whether combining clinical data, imaging, lab and genetic information can predict who will have stroke or cognitive decline among people with Moyamoya.
-
5T MRI and Metabolomics to Predict Hemorrhage Risk in Moyamoya Disease
This study tests whether advanced 5T MRI imaging and metabolomics can help predict which moyamoya patients are at higher risk of intracranial hemorrhage.
-
XR-assisted CT-guided localization for EC-IC bypass in Moyamoya and chronic cerebral ischemia
The study tests whether a metaverse-based surgical simulation with extended reality helps localize vessels during EC-IC bypass for moyamoya disease or chronic cerebral ischemia.
-
Family screening and early detection for moyamoya disease
This project will try to find biological signs and 5T high-resolution MRI features that could detect moyamoya earlier in people with the disease, their first-degree relatives, and people without a family history.
-
Remimazolam: target-controlled infusion versus manual infusion during cerebrovascular bypass
This trial will test whether target-controlled infusion uses less remimazolam than manual infusion in adults undergoing cerebrovascular bypass surgery for moyamoya disease.
-
Cardiac index–guided blood flow management during pediatric Moyamoya EDAS surgery
This study will test whether using each child's cardiac index to guide fluids and hemodynamic care during EDAS lowers postoperative transient ischemic episodes in children with Moyamoya disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.